Effects of intravenous magnesium chloride reverses left ventricular end-diastolic pressure in coronary artery disease

In conclusion, our study shows that intravenous administration of MgCl reverses increasesed LV enddiastolic pressure in patients with coronary artery disease. Magnesium may be a clinically valuable drug for reducing the ischemic burden originating from increased LV end-diastolic pressure.